Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies

Published:2023-10 Issue: Volume:573 Page:216382
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Natu Jay,Nagaraju Ganji Purnachandra^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference95 articles.

1. Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumoral necrosis;Noda;BMC Med. Imag.,2022

2. Pancreatic cancer: a review of epidemiology, trend, and risk factors;Hu;World J. Gastroenterol.,2021

3. Diagnostic intervals and pancreatic ductal adenocarcinoma (PDAC) resectability: a single-center retrospective analysis;Deshwar;Ann. Pancreat. Cancer,2018

4. Genomic heterogeneity of pancreatic ductal adenocarcinoma and its clinical impact;Gutiérrez;Cancers,2021

5. Targeting the tumor microenvironment of pancreatic ductal adenocarcinoma using nano-phytomedicines;Girish;Semin. Cancer Biol.,2022

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis;Cancer Letters;2024-10

2. YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer;Cancer Letters;2024-10

3. Development of cationic pH-sensitive liposomes with Gemcitabine loading and Fucoidan-coating against pancreatic cancer cells;Journal of Drug Delivery Science and Technology;2024-10

4. Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes;Cancer Letters;2024-09

5. Addressing chemoresistance with a lipid gemcitabine nanotherapeutic strategy for effective treatment of pancreatic cancer;Nano Research;2024-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3